What is Context Therapeutics Inc. Common Stock's Market Cap?

Context Therapeutics Inc. Common Stock's Market Cap is $34.0M, based on as-reported figures from SEC (XBRL) filings.

What is Context Therapeutics Inc. Common Stock's Enterprise Value?

Context Therapeutics Inc. Common Stock's Enterprise Value is -$9.0M, based on as-reported figures from SEC (XBRL) filings.

What is Context Therapeutics Inc. Common Stock's EV / EBITDA?

Context Therapeutics Inc. Common Stock's EV / EBITDA is 0.2×, based on as-reported figures from SEC (XBRL) filings.

What is Context Therapeutics Inc. Common Stock's Net Income (TTM)?

Context Therapeutics Inc. Common Stock's Net Income (TTM) is -$46.0M, based on as-reported figures from SEC (XBRL) filings.

What is Context Therapeutics Inc. Common Stock's EBITDA?

Context Therapeutics Inc. Common Stock's EBITDA is -$48.7M, based on as-reported figures from SEC (XBRL) filings.

What is Context Therapeutics Inc. Common Stock's Diluted EPS (TTM)?

Context Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -0.50, based on as-reported figures from SEC (XBRL) filings.

What is Context Therapeutics Inc. Common Stock's Net Debt?

Context Therapeutics Inc. Common Stock's Net Debt is -$43.0M, based on as-reported figures from SEC (XBRL) filings.

Context Therapeutics Inc. Common Stock (CNTX) Financial Statements

Context Therapeutics Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG011YW6J46

XNAS · usd

0.37▼ 0.01 (-1.67%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.38

Day's Range0.37 – 0.38

52-Week Range0.35 – 3.62

Volume642.0K

Avg Volume1.9M

Share Statistics

Shares Outstanding

Employees15

ExchangeXNAS

Listed2021-10-20

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Context Therapeutics Inc. Common Stock (CNTX)

What is Context Therapeutics Inc. Common Stock's Market Cap?: Context Therapeutics Inc. Common Stock's Market Cap is $34.0M, based on as-reported figures from SEC (XBRL) filings.
What is Context Therapeutics Inc. Common Stock's Enterprise Value?: Context Therapeutics Inc. Common Stock's Enterprise Value is -$9.0M, based on as-reported figures from SEC (XBRL) filings.
What is Context Therapeutics Inc. Common Stock's EV / EBITDA?: Context Therapeutics Inc. Common Stock's EV / EBITDA is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Context Therapeutics Inc. Common Stock's Net Income (TTM)?: Context Therapeutics Inc. Common Stock's Net Income (TTM) is -$46.0M, based on as-reported figures from SEC (XBRL) filings.
What is Context Therapeutics Inc. Common Stock's EBITDA?: Context Therapeutics Inc. Common Stock's EBITDA is -$48.7M, based on as-reported figures from SEC (XBRL) filings.
What is Context Therapeutics Inc. Common Stock's Diluted EPS (TTM)?: Context Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -0.50, based on as-reported figures from SEC (XBRL) filings.
What is Context Therapeutics Inc. Common Stock's Net Debt?: Context Therapeutics Inc. Common Stock's Net Debt is -$43.0M, based on as-reported figures from SEC (XBRL) filings.